ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. develops and markets automated technologies for cell-based therapies, including the CAR-TXpress platform for CAR-T immunotherapy. Its suite of solutions includes the AXP II Automated Cell Separation System, BioArchive Automated Cryopreservation System, PXP Point-of-Care System, and X-Series products for cell isolation and purification. These products cater to clinical biobanking, point-of-care applications, and immuno-oncology, addressing the critical unmet need for large-scale cellular processing. The company generates revenue through the sale of its automated systems and platforms, which streamline the manufacturing process for cell-based therapies and contribute to advancements in the emerging CAR-T immunotherapy market.

Products

• CAR-TXpress platform

• AXP II Automated Cell Separation System

• BioArchive Automated Cryopreservation System

• PXP Point-of-Care System

• X-Series products